For the twelve months ended Oct 2, 2026, Exelixis Inc. reported $2.50B of revenue and $885.14M of net income.
EXEL revenue was $658.70M in fiscal Q3 2026 (ended Oct 2, 2026), up 10.2% from a year earlier and up 4.8% from the prior quarter. For the full fiscal 2025 it was $2.32B, up 7.0% from fiscal 2024. Compound annual growth was +18.6% over 5 years and +51.2% over 10 years. It rose in each of the last 10 fiscal years. Fiscal 2025 is the highest of the 15 fiscal years on file.
EXEL net income was $218.09M in fiscal Q3 2026 (ended Oct 2, 2026), up 12.7% from a year earlier and up 2.9% from the prior quarter. For the full fiscal 2025 it was $782.57M, up 50.1% from fiscal 2024. Compound annual growth was +47.6% over 5 years. It rose in 5 of the last 8 fiscal years. Fiscal 2025 is the highest of the 15 fiscal years on file.
EXEL diluted EPS was $0.85 in fiscal Q3 2026 (ended Oct 2, 2026), up 23.2% from a year earlier and up 3.7% from the prior quarter. For the full fiscal 2025 it was $2.78, up 58.0% from fiscal 2024. Compound annual growth was +51.4% over 5 years.
EXEL free cash flow was $277.47M in fiscal Q3 2026 (ended Oct 2, 2026), down 3.9% from a year earlier and down 7.8% from the prior quarter. For the full fiscal 2025 it was $875.84M, up 30.4% from fiscal 2024. Compound annual growth was +37.4% over 5 years. It rose in 5 of the last 9 fiscal years. Fiscal 2025 is the highest of the 15 fiscal years on file.
| Line item | Jan 2, 2026 | Jan 3, 2025 | Dec 29, 2023 | Dec 30, 2022 | Dec 31, 2021 | Jan 1, 2021 | Jan 3, 2020 | Dec 28, 2018 | Dec 29, 2017 | Dec 31, 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $2.32B | $2.17B | $1.83B | $1.61B | $1.43B | $987.54M | $967.77M | $853.83M | $452.48M | $191.45M |
| Cost of revenue | $83.70M | $76.22M | $72.55M | $57.91M | $52.87M | $36.27M | $33.10M | $26.35M | $15.07M | $6.55M |
| Gross profit | $2.24B | $2.09B | $1.76B | $1.55B | $1.38B | $951.27M | $934.68M | $827.48M | $437.41M | $184.90M |
| Research and development | $825.00M | $910.41M | $1.04B | $891.81M | $693.72M | $547.85M | $336.96M | $182.26M | $112.17M | $95.97M |
| Selling, general and admin | $518.73M | $492.13M | $542.71M | $459.86M | $401.71M | $293.36M | $228.24M | $206.37M | $159.33M | $116.14M |
| Operating income | $872.19M | $604.62M | $170.88M | $201.48M | $286.67M | $110.06M | $369.47M | $438.86M | $165.91M | -$28.12M |
| Interest expense | - | - | - | - | - | - | $0 | $0 | $8.68M | $33.06M |
| Pre-tax income | - | - | - | - | - | $130.84M | $398.11M | $452.09M | $158.58M | -$70.22M |
| Income tax | $158.64M | $160.37M | $49.76M | $52.07M | $63.09M | $19.06M | $77.10M | -$237.98M | $4.35M | $0 |
| Net income | $782.57M | $521.27M | $207.76M | $182.28M | $231.06M | $111.78M | $321.01M | $690.07M | $154.23M | -$70.22M |
| EPS, basic | $2.88 | $1.80 | $0.65 | $0.57 | $0.73 | $0.36 | $1.06 | $2.32 | $0.52 | -$0.28 |
| EPS, diluted | $2.78 | $1.76 | $0.65 | $0.56 | $0.72 | $0.35 | $1.02 | $2.21 | $0.49 | -$0.28 |
| Diluted shares | 281.9M | 296.1M | 321.5M | 324.6M | 322.4M | 318.0M | 315.0M | 312.8M | 312.0M | 250.5M |
| Line item | Jan 2, 2026 | Jan 3, 2025 | Dec 29, 2023 | Dec 30, 2022 | Dec 31, 2021 | Jan 1, 2021 | Jan 3, 2020 | Dec 28, 2018 | Dec 29, 2017 | Dec 31, 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | $482.49M | $217.37M | $262.99M | $502.68M | $663.89M | $320.77M | $268.14M | $315.88M | $183.16M | $151.69M |
| Short-term investments | $576.60M | $893.90M | $732.31M | $807.27M | $819.90M | $887.32M | $585.74M | $378.56M | $204.61M | $268.12M |
| Receivables | $286.92M | $265.44M | $237.41M | $214.78M | $282.65M | $160.88M | $119.07M | $162.77M | $77.30M | $40.44M |
| Inventory | $21.69M | $22.39M | $17.32M | $33.30M | $27.49M | $20.97M | $12.89M | $9.84M | $6.66M | $3.34M |
| Current assets | $1.44B | $1.47B | $1.32B | $1.62B | $1.83B | $1.45B | $1.01B | $897.02M | $484.87M | $469.00M |
| Goodwill | $63.68M | $63.68M | $63.68M | $63.68M | $63.68M | $63.68M | $63.68M | $63.68M | $63.68M | $63.68M |
| Total assets | $2.84B | $2.95B | $2.94B | $3.07B | $2.62B | $2.14B | $1.89B | $1.42B | $655.29M | $595.74M |
| Current liabilities | $405.64M | $403.77M | $394.28M | $324.36M | $337.59M | $204.66M | $142.75M | $105.47M | $115.17M | $268.79M |
| Short-term debt | - | - | - | - | - | - | - | - | - | $189.12M |
| Long-term debt | - | - | - | - | - | - | - | - | - | $0 |
| Total debt | - | - | - | - | - | - | - | - | $0 | $189.12M |
| Total liabilities | $683.10M | $703.49M | $678.45M | $583.06M | $405.62M | $258.22M | $199.70M | $134.83M | $370.33M | $506.42M |
| Shareholders' equity | $2.16B | $2.24B | $2.26B | $2.49B | $2.21B | $1.88B | $1.69B | $1.29B | $284.96M | $89.32M |
| Line item | Jan 2, 2026 | Jan 3, 2025 | Dec 29, 2023 | Dec 30, 2022 | Dec 31, 2021 | Jan 1, 2021 | Jan 3, 2020 | Dec 28, 2018 | Dec 29, 2017 | Dec 31, 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $884.27M | $699.97M | $333.32M | $362.61M | $400.80M | $208.98M | $526.96M | $415.72M | $165.61M | $206.30M |
| Capital expenditures | $8.43M | $28.43M | $40.47M | $27.71M | $54.23M | $30.34M | $12.83M | $33.30M | $21.14M | $1.70M |
| Free cash flow | $875.84M | $671.54M | $292.86M | $334.91M | $346.58M | $178.64M | $514.12M | $382.42M | $144.47M | $204.59M |
| Investing cash flow | $350.44M | -$116.78M | -$26.95M | -$524.41M | -$42.88M | -$131.22M | -$587.25M | -$297.85M | $36.80M | -$216.05M |
| Financing cash flow | -$969.59M | -$628.81M | -$546.05M | $586.0K | -$14.80M | -$25.13M | $12.55M | $9.69M | -$169.93M | $19.80M |
| Share repurchases | $947.51M | $652.03M | $550.38M | $0 | $0 | - | - | - | - | - |
| Stock-based compensation | $112.98M | $93.84M | $106.34M | $107.57M | $119.82M | $105.07M | $56.60M | $40.63M | $23.94M | $22.91M |
| Depreciation and amortization | $29.05M | $28.80M | $25.72M | $20.88M | $13.63M | $9.14M | $8.35M | $4.92M | $1.19M | $1.00M |
| Line item | Jan 2, 2026 | Jan 3, 2025 | Dec 29, 2023 | Dec 30, 2022 | Dec 31, 2021 | Jan 1, 2021 | Jan 3, 2020 | Dec 28, 2018 | Dec 29, 2017 | Dec 31, 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue growth, YoY | 7.0% | 18.5% | 13.6% | 12.3% | 45.3% | 2.0% | 13.3% | 88.7% | 136.3% | 415.0% |
| Net income growth, YoY | 50.1% | 150.9% | 14.0% | -21.1% | 106.7% | -65.2% | -53.5% | 347.4% | - | - |
| EPS growth, YoY | 58.0% | 170.8% | 16.1% | -22.2% | 105.7% | -65.7% | -53.8% | 351.0% | - | - |
| Gross margin | 96.4% | 96.5% | 96.0% | 96.4% | 96.3% | 96.3% | 96.6% | 96.9% | 96.7% | 96.6% |
| Operating margin | 37.6% | 27.9% | 9.3% | 12.5% | 20.0% | 11.1% | 38.2% | 51.4% | 36.7% | -14.7% |
| Net margin | 33.7% | 24.0% | 11.4% | 11.3% | 16.1% | 11.3% | 33.2% | 80.8% | 34.1% | -36.7% |
| Free cash flow margin | 37.7% | 31.0% | 16.0% | 20.8% | 24.2% | 18.1% | 53.1% | 44.8% | 31.9% | 106.9% |
| Return on equity | 36.2% | 23.2% | 9.2% | 7.3% | 10.5% | 5.9% | 19.0% | 53.6% | 54.1% | -78.6% |
| Return on assets | 27.5% | 17.7% | 7.1% | 5.9% | 8.8% | 5.2% | 17.0% | 48.5% | 23.5% | -11.8% |
| Current ratio | 3.56 | 3.63 | 3.34 | 4.99 | 5.43 | 7.06 | 7.08 | 8.50 | 4.21 | 1.74 |
| Debt to equity | - | - | - | - | - | - | - | - | 0.00 | 2.12 |
| Line item | Oct 2, 2026 | Jul 3, 2026 | Apr 3, 2026 | Jan 2, 2026 | Oct 3, 2025 | Jul 4, 2025 | Apr 4, 2025 | Jan 3, 2025 | Sep 27, 2024 | Jun 28, 2024 | Mar 29, 2024 | Dec 29, 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $658.70M | $628.69M | $610.81M | $598.66M | $597.75M | $568.26M | $555.45M | $566.75M | $539.54M | $637.18M | $425.23M | $479.65M |
| Cost of revenue | $26.23M | $20.66M | $19.95M | $26.48M | $18.57M | $19.47M | $19.17M | $19.96M | $17.33M | $17.67M | $21.26M | $21.75M |
| Gross profit | $632.46M | $608.03M | $590.86M | $572.18M | $579.18M | $548.79M | $536.27M | $546.79M | $522.21M | $619.51M | $403.97M | $457.90M |
| Research and development | $209.48M | $211.99M | $199.92M | $213.25M | $199.16M | $200.36M | $212.23M | $249.00M | $222.57M | $211.15M | $227.69M | $244.67M |
| Selling, general and admin | $154.56M | $147.63M | $139.60M | $123.02M | $123.66M | $134.86M | $137.18M | $134.33M | $111.80M | $132.01M | $113.98M | $131.44M |
| Operating income | $268.42M | $248.41M | $251.34M | $235.22M | $236.54M | $213.58M | $186.86M | $163.21M | $136.07M | $275.87M | $29.46M | $81.79M |
| Income tax | $64.69M | $50.63M | $57.22M | $8.16M | $58.84M | $45.57M | $46.07M | $44.91M | $36.78M | $66.73M | $11.95M | $17.52M |
| Net income | $218.09M | $212.05M | $210.47M | $244.53M | $193.58M | $184.85M | $159.62M | $139.86M | $117.97M | $226.12M | $37.32M | $85.52M |
| EPS, basic | $0.88 | $0.85 | $0.81 | $0.91 | $0.72 | $0.68 | $0.57 | $0.49 | $0.41 | $0.78 | $0.12 | $0.28 |
| EPS, diluted | $0.85 | $0.82 | $0.79 | $0.89 | $0.69 | $0.65 | $0.55 | $0.47 | $0.40 | $0.77 | $0.12 | $0.28 |
| Diluted shares | 255.8M | 259.7M | 267.3M | - | 278.5M | 284.4M | 288.2M | - | 291.5M | 294.0M | 305.5M | - |
| Line item | Oct 2, 2026 | Jul 3, 2026 | Apr 3, 2026 | Jan 2, 2026 | Oct 3, 2025 | Jul 4, 2025 | Apr 4, 2025 | Jan 3, 2025 | Sep 27, 2024 | Jun 28, 2024 | Mar 29, 2024 | Dec 29, 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | $304.77M | $281.45M | $226.15M | $482.49M | $376.30M | $164.43M | $183.75M | $217.37M | $258.35M | $198.46M | $259.56M | $262.99M |
| Short-term investments | $587.24M | $557.94M | $551.05M | $576.60M | $612.24M | $626.66M | $847.56M | $893.90M | $930.82M | $803.54M | $703.70M | $732.31M |
| Receivables | $328.47M | $322.21M | $328.95M | $286.92M | $309.73M | $292.35M | $281.64M | $265.44M | $269.71M | $396.58M | $240.58M | $237.41M |
| Inventory | $29.87M | $28.73M | $26.61M | $21.69M | $27.40M | $23.48M | $24.85M | $22.39M | $21.01M | $20.61M | $21.11M | $17.32M |
| Current assets | $1.32B | $1.25B | $1.21B | $1.44B | $1.40B | $1.18B | $1.40B | $1.47B | $1.55B | $1.48B | $1.29B | $1.32B |
| Goodwill | $63.68M | $63.68M | $63.68M | $63.68M | $63.68M | $63.68M | $63.68M | $63.68M | $63.68M | $63.68M | $63.68M | $63.68M |
| Total assets | $2.51B | $2.49B | $2.59B | $2.84B | $2.82B | $2.68B | $2.84B | $2.95B | $2.96B | $2.77B | $2.80B | $2.94B |
| Current liabilities | $411.88M | $361.93M | $370.98M | $405.64M | $373.78M | $336.11M | $399.10M | $403.77M | $394.35M | $345.70M | $373.01M | $394.28M |
| Total liabilities | $679.66M | $650.47M | $657.85M | $683.10M | $662.85M | $644.54M | $706.22M | $703.49M | $684.86M | $653.39M | $675.74M | $678.45M |
| Shareholders' equity | $1.83B | $1.84B | $1.94B | $2.16B | $2.16B | $2.03B | $2.13B | $2.24B | $2.28B | $2.12B | $2.13B | $2.26B |
| Line item | Oct 2, 2026 | Jul 3, 2026 | Apr 3, 2026 | Jan 2, 2026 | Oct 3, 2025 | Jul 4, 2025 | Apr 4, 2025 | Jan 3, 2025 | Sep 27, 2024 | Jun 28, 2024 | Mar 29, 2024 | Dec 29, 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $279.96M | $307.74M | $251.84M | $333.51M | $290.32M | $48.99M | $211.44M | $240.26M | $271.34M | $119.55M | $68.82M | $10.57M |
| Capital expenditures | $2.49M | $6.82M | $1.51M | $1.16M | $1.48M | $2.84M | $2.95M | $3.98M | $8.20M | $6.57M | $9.69M | $13.13M |
| Free cash flow | $277.47M | $300.93M | $250.34M | $332.36M | $288.84M | $46.16M | $208.49M | $236.29M | $263.14M | $112.98M | $59.13M | -$2.56M |
| Investing cash flow | -$6.71M | $91.43M | -$51.07M | $27.24M | $25.41M | $248.03M | $49.76M | -$93.20M | -$217.15M | $81.77M | $111.79M | $61.74M |
| Financing cash flow | -$249.92M | -$343.88M | -$457.11M | -$254.57M | -$103.86M | -$316.34M | -$294.82M | -$188.03M | $5.70M | -$262.42M | -$184.05M | -$206.17M |
| Share repurchases | $249.96M | $322.97M | $430.35M | $257.62M | $104.03M | $301.92M | $283.93M | $190.41M | $11.93M | $264.32M | $185.38M | $209.30M |
| Stock-based compensation | $28.72M | $32.56M | $29.05M | $20.10M | $30.89M | $36.07M | $25.93M | $26.35M | $23.02M | $25.35M | $19.11M | $24.31M |
| Depreciation and amortization | $6.93M | $6.98M | $6.95M | $6.95M | $7.42M | $7.34M | $7.34M | $7.64M | $7.45M | $7.33M | $6.38M | $6.53M |
| Line item | Oct 2, 2026 | Jul 3, 2026 | Apr 3, 2026 | Jan 2, 2026 | Oct 3, 2025 | Jul 4, 2025 | Apr 4, 2025 | Jan 3, 2025 | Sep 27, 2024 | Jun 28, 2024 | Mar 29, 2024 | Dec 29, 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue growth, YoY | 10.2% | 10.6% | 10.0% | 5.6% | 10.8% | -10.8% | 30.6% | 18.2% | 14.3% | 35.6% | 4.0% | 13.1% |
| Net income growth, YoY | 12.7% | 14.7% | 31.9% | 74.8% | 64.1% | -18.3% | 327.7% | 63.5% | 11232.7% | 178.5% | -6.8% | - |
| EPS growth, YoY | 23.2% | 26.2% | 43.6% | 89.4% | 72.5% | -15.6% | 358.3% | 67.9% | - | 208.0% | 0.0% | - |
| Gross margin | 96.0% | 96.7% | 96.7% | 95.6% | 96.9% | 96.6% | 96.5% | 96.5% | 96.8% | 97.2% | 95.0% | 95.5% |
| Operating margin | 40.8% | 39.5% | 41.1% | 39.3% | 39.6% | 37.6% | 33.6% | 28.8% | 25.2% | 43.3% | 6.9% | 17.1% |
| Net margin | 33.1% | 33.7% | 34.5% | 40.8% | 32.4% | 32.5% | 28.7% | 24.7% | 21.9% | 35.5% | 8.8% | 17.8% |
| Free cash flow margin | 42.1% | 47.9% | 41.0% | 55.5% | 48.3% | 8.1% | 37.5% | 41.7% | 48.8% | 17.7% | 13.9% | -0.5% |
| Current ratio | 3.21 | 3.46 | 3.26 | 3.56 | 3.75 | 3.51 | 3.50 | 3.63 | 3.93 | 4.27 | 3.46 | 3.34 |
Source: XBRL data Exelixis Inc. files with the SEC, latest filing dated Oct 29, 2026 (see filings on SEC EDGAR). Provided for information only, not investment advice. Check the filing before relying on a number.
* Worked out from the filings rather than stated in them: Q4 is the full year less the first nine months.
Per-share figures are as filed. The filings show no stock split in these periods.
EPS growth is left out where the share count moved enough to suggest a split the filings do not show. Growth rates need a positive starting figure. CAGR is compound annual growth between fiscal years. The CSV holds every period on file, in full figures, from the same SEC filings.
| Company | Revenue | Growth | Net income | Net margin | Market cap |
|---|---|---|---|---|---|
| EXEL | $2.50B | +9.1% | $885.14M | 35.5% | $16.98B |
| AMGN | $38.90B | +8.2% | $9.39B | 24.1% | $249.05B |
| GILD | $30.99B | +6.5% | -$3.86B | -12.5% | $207.00B |
| MRNA | $2.52B | +13.1% | -$2.79B | -110.5% | $101.48B |
| ARGX | $4.25B | +88.6% | $1.29B | 30.4% | $57.55B |
| RVMD | $0 | - | -$1.13B | - | $41.59B |
| BIIB | $10.30B | +2.3% | $347.50M | 3.4% | $36.71B |
| BNTX | €2.87B | +4.3% | -€1.14B | -39.6% | $21.98B |
| NBIX | $3.70B | +38.0% | $702.50M | 19.0% | $16.66B |